MedTrace Logo

MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer

NCT01792024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-03-13

Study results available
· View outcomes & findings →

Summary

This phase II trial studies how well magnetic resonance (MR)-guided laser interstitial thermal therapy works in treating patients with prostate cancer. Laser therapy uses intense, narrow beams of light to cut and destroy tissue and may help treat prostate cancer

Conditions

  • Stage I Prostate Cancer
  • Stage II Prostate Carcinoma

Interventions

DEVICE

Visualase Thermal Therapy

MR guided laser ablation of prostate cancer

PROCEDURE

magnetic resonance imaging

Undergo MR-guided LITT

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Chicago

    lead OTHER

Principal Investigators

  • Aytekin Oto · University of Chicago Comprehensive Cancer Center

  • Scott Eggener, MD · University of Chicago

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-28
Primary Completion
2015-09-16
Completion
2015-09-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01792024 on ClinicalTrials.gov